Impact on Elderly Skin Due to Wet Pad Application.

March 14, 2024 updated by: Essity Hygiene and Health AB

Impact to Skin Due to Wet Pad Application. Skin Status and Change in the Stratum Corneum as Measured With 4 Instruments in an Elderly Population.

The clinical study aims to measure the changes in the stratum corneum on older healthy participants due to the application of a wet pad on the forearm. Participants are subject to baseline measures of TransEpidermalWaterLoss (TEWL), skin hydration (SH), pH and water profile (raman spectroscopy). Dry or wet pads are then added to the skin and worn for two hours. After a recovery period, the SkinSurfaceWaterLoss (SSWL) and skin hydration and water profile is measured. The study is conducted over a single visit. Pads on the arms consist of incontinence product cutouts and are loaded to 50% or 100% capacity. The endpoints are the changes in stratum corneum as measured by the instruments during the visit.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mölndal, Sweden, SE40503
        • Essity Study site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Men and women ≥ 65 years.
  2. Mentally and physically able to participate in this study.
  3. Written informed consent to participate in this study.
  4. Intact skin on the volar forearms without skin irritation.

Exclusion Criteria:

  1. Have any known allergies or intolerances to one or several components of the absorbing incontinence product.
  2. Suffer from excessive sweating, hyperhidrosis.
  3. Have any other condition that makes participation in the clinical investigation inappropriate, as judged by investigator.
  4. Not be of childbearing potential.
  5. Have an alcohol and/or drug dependency.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention arm
Single arm study, all participants get pads applied to their forearms
Single arm design in which each participant act as its own control. Wet or Dry pads are applied to the participants forearms.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change Trans Epidermal Water loss
Time Frame: 2 hours
As measured by Dermalab instrument. Transepidermal water loss (TEWL) from dry skin and the subsequent skin surface water loss (SSWL) from wet skin
2 hours
Change in skin hydration
Time Frame: 2 hours
Skin hydration (SH) as measured with moisturemeter instrument
2 hours
Change in Skin water profile
Time Frame: 2 hours
As measured Confocal raman microspectometry. The water content of skin at different depths.
2 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in skin surface pH
Time Frame: 2 hours
Skin surface pH measurement using pH meter
2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shabira Abbas, PhD, Essity Hygiene and Health AB

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 14, 2023

Primary Completion (Actual)

February 9, 2024

Study Completion (Actual)

February 28, 2024

Study Registration Dates

First Submitted

January 31, 2024

First Submitted That Met QC Criteria

January 31, 2024

First Posted (Actual)

February 8, 2024

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 14, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • DROPBOX

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Incontinence

Clinical Trials on Pads

Subscribe